United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Is the cure for PTSD waiting in the wings? FDA says not yet! In a significant regulatory decision, the U.S. Food and Drug Administration (FDA) has decided not to approve the… byPallavi MadhirajuAugust 10, 2024